Immunic Announces Oversubscribed Private Placement Of Up To USD 400 Million To Accelerate Transformation Into Commercial-Stage Company

Reuters

Feb 13

Feb 13 (Reuters) - Immunic Inc ::
*IMMUNIC ANNOUNCES OVERSUBSCRIBED PRIVATE PLACEMENT OF UP TO USD 400 MILLION TO ACCELERATE TRANSFORMATION INTO COMMERCIAL-STAGE COMPANY
*IMMUNIC INC: PROCEEDS OF FINANCING EXPECTED TO SUPPORT CO'S TRANSITION FROM RESEARCH & DEVELOPMENT-FOCUSED CO INTO FULLY INTEGRATED COMMERCIAL ENTITY
*IMMUNIC INC - CO-FOUNDER AND CHIEF EXECUTIVE OFFICER DANIEL VITT AND BOARD OF DIRECTORS WILL BEGIN A SEARCH FOR A NEW CEO

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 13-FEB-202611:30:00.027 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2611159599"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2611159599\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2611159599?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-13 19:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611159599","market":"nz","top_or_hot":-1,"title":"Immunic Announces Oversubscribed Private Placement Of Up To USD 400 Million To Accelerate Transformation Into Commercial-Stage Company","media":"Reuters","content":"<html><body>Feb 13 (Reuters) - Immunic Inc <imux.o>::<br/>*IMMUNIC ANNOUNCES OVERSUBSCRIBED PRIVATE PLACEMENT OF UP TO USD 400 MILLION TO ACCELERATE TRANSFORMATION INTO COMMERCIAL-STAGE COMPANY<br/>*IMMUNIC INC: PROCEEDS OF FINANCING EXPECTED TO SUPPORT CO'S TRANSITION FROM RESEARCH &amp; DEVELOPMENT-FOCUSED CO INTO FULLY INTEGRATED COMMERCIAL ENTITY<br/>*IMMUNIC INC - CO-FOUNDER AND CHIEF EXECUTIVE OFFICER DANIEL VITT AND BOARD OF DIRECTORS WILL BEGIN A SEARCH FOR A NEW CEO<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 13-FEB-202611:30:00.027 GMT</imux.o></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Immunic Announces Oversubscribed Private Placement Of Up To USD 400 Million To Accelerate Transformation Into Commercial-Stage Company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImmunic Announces Oversubscribed Private Placement Of Up To USD 400 Million To Accelerate Transformation Into Commercial-Stage Company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-13 19:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>Feb 13 (Reuters) - Immunic Inc <imux.o>::<br/>*IMMUNIC ANNOUNCES OVERSUBSCRIBED PRIVATE PLACEMENT OF UP TO USD 400 MILLION TO ACCELERATE TRANSFORMATION INTO COMMERCIAL-STAGE COMPANY<br/>*IMMUNIC INC: PROCEEDS OF FINANCING EXPECTED TO SUPPORT CO'S TRANSITION FROM RESEARCH &amp; DEVELOPMENT-FOCUSED CO INTO FULLY INTEGRATED COMMERCIAL ENTITY<br/>*IMMUNIC INC - CO-FOUNDER AND CHIEF EXECUTIVE OFFICER DANIEL VITT AND BOARD OF DIRECTORS WILL BEGIN A SEARCH FOR A NEW CEO<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 13-FEB-202611:30:00.027 GMT</imux.o></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nRSD7YBxSx:1","article_id":"2611159599","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611159599","pubTimestamp":1770983178,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Feb 13 (Reuters) - Immunic Inc ::*IMMUNIC ANNOUNCES OVERSUBSCRIBED PRIVATE PLACEMENT OF UP TO USD 400 MILLION TO ACCELERATE TRANSFORMATION INTO COMMERCIAL-STAGE COMPANY*IMMUNIC INC: PROCEEDS OF FINANC","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IMUX":"Immunic, Inc."},"translate_title":"Immunic宣布超额认购高达4亿美元的私募加速向商业阶段公司转型","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMUX":0.9},"content_text":"Feb 13 (Reuters) - Immunic Inc ::*IMMUNIC ANNOUNCES OVERSUBSCRIBED PRIVATE PLACEMENT OF UP TO USD 400 MILLION TO ACCELERATE TRANSFORMATION INTO COMMERCIAL-STAGE COMPANY*IMMUNIC INC: PROCEEDS OF FINANCING EXPECTED TO SUPPORT CO'S TRANSITION FROM RESEARCH & DEVELOPMENT-FOCUSED CO INTO FULLY INTEGRATED COMMERCIAL ENTITY*IMMUNIC INC - CO-FOUNDER AND CHIEF EXECUTIVE OFFICER DANIEL VITT AND BOARD OF DIRECTORS WILL BEGIN A SEARCH FOR A NEW CEO  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-FEB-202611:30:00.027 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive,shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}